Exploring the nuclear proteins, viral capsid protein, and early antigen protein using immunoinformatic and molecular modeling approaches to design a vaccine candidate against Epstein Barr virus-Reference-Cited by-同舟云学术

Exploring the nuclear proteins, viral capsid protein, and early antigen protein using immunoinformatic and molecular modeling approaches to design a vaccine candidate against Epstein Barr virus

Published:2024-07-22 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Oladipo Elijah Kolawole,Ojo Taiwo Ooreoluwa,Elegbeleye Oluwabamise Emmanuel,Bolaji Olawale Quadri,Oyewole Moyosoluwa Precious,Ogunlana Abdeen Tunde,Olalekan Emmanuel Obanijesu,Abiodun Bamidele,Adediran Daniel Adewole,Obideyi Oluwaseun Adeola,Olufemi Seun Elijah,Salamatullah Ahmad Mohammad,Bourhia Mohammed,Younous Youssouf Ali,Adelusi Temitope Isaac

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-66828-x.pdf

Reference89 articles.

1. Nowalk, A. & Green, M. Epstein–Barr virus. Microbiol. Spectr. 4(3), 3–4 (2016).

2. Martorelli, D. et al. Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein–Barr-virus-driven disorders. J. Immunol. Res. https://doi.org/10.1155/2012/931952 (2012).

3. Longnecker, R. M., Kieff, E. & Cohen, J. I. Epstein–Barr virus. In Fields Virology 6th edn (Wolters Kluwer Health Adis (ESP), 2013).

4. Thorley-Lawson, D. A., Hawkins, J. B., Tracy, S. I. & Shapiro, M. The pathogenesis of Epstein–Barr virus persistent infection. Curr. Opin. Virol. 3(3), 227–232 (2013).

5. Chen, F. et al. A subpopulation of normal B cells latently infected with Epstein–Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69(6), 3752–3758 (1995).